KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Medpace Holdings (MEDP) Gross Margin (2016 - 2025)

Medpace Holdings' Gross Margin history spans 11 years, with the latest figure at 28.98% for Q4 2025.

  • For Q4 2025, Gross Margin fell 425.0% year-over-year to 28.98%; the TTM value through Dec 2025 reached 30.06%, down 106.0%, while the annual FY2025 figure was 30.06%, 106.0% down from the prior year.
  • Gross Margin reached 28.98% in Q4 2025 per MEDP's latest filing, down from 29.84% in the prior quarter.
  • In the past five years, Gross Margin ranged from a high of 33.23% in Q4 2024 to a low of 26.82% in Q2 2021.
  • Average Gross Margin over 5 years is 29.49%, with a median of 29.64% recorded in 2021.
  • Peak YoY movement for Gross Margin: skyrocketed 578bps in 2024, then plummeted -425bps in 2025.
  • A 5-year view of Gross Margin shows it stood at 28.52% in 2021, then rose by 3bps to 29.37% in 2022, then dropped by -7bps to 27.45% in 2023, then rose by 21bps to 33.23% in 2024, then dropped by -13bps to 28.98% in 2025.
  • Per Business Quant, the three most recent readings for MEDP's Gross Margin are 28.98% (Q4 2025), 29.84% (Q3 2025), and 29.84% (Q2 2025).